Natalizumab wearing-off symptoms: Patients with MS on extended interval dosing may not "mind the gap"

Ellen M. Mowry; Dennis Bourdette

doi:10.1212/WNL.0000000000008358

Natalizumab wearing-off symptoms: Patients with MS on extended interval dosing may not "mind the gap"

Ellen M. Mowry, Dennis Bourdette

School of Medicine

Research output: Contribution to journal › Editorial › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	735-736
Number of pages	2
Journal	Neurology
Volume	93
Issue number	17
DOIs	https://doi.org/10.1212/WNL.0000000000008358
State	Published - Oct 22 2019

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/WNL.0000000000008358

Cite this

@article{3a3ebc0d9b884d4a9904c1e27d677de7,

title = "Natalizumab wearing-off symptoms: Patients with MS on extended interval dosing may not {"}mind the gap{"}",

author = "Mowry, {Ellen M.} and Dennis Bourdette",

year = "2019",

month = oct,

day = "22",

doi = "10.1212/WNL.0000000000008358",

language = "English (US)",

volume = "93",

pages = "735--736",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "17",

}

TY - JOUR

T1 - Natalizumab wearing-off symptoms

T2 - Patients with MS on extended interval dosing may not "mind the gap"

AU - Mowry, Ellen M.

AU - Bourdette, Dennis

PY - 2019/10/22

Y1 - 2019/10/22

UR - http://www.scopus.com/inward/record.url?scp=85073665346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073665346&partnerID=8YFLogxK

U2 - 10.1212/WNL.0000000000008358

DO - 10.1212/WNL.0000000000008358

M3 - Editorial

C2 - 31551259

AN - SCOPUS:85073665346

SN - 0028-3878

VL - 93

SP - 735

EP - 736

JO - Neurology

JF - Neurology

IS - 17

ER -

Natalizumab wearing-off symptoms: Patients with MS on extended interval dosing may not "mind the gap"

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this